Hayes M. Dansky

5.8k total citations · 2 hit papers
51 papers, 3.9k citations indexed

About

Hayes M. Dansky is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Hayes M. Dansky has authored 51 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 17 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Molecular Biology. Recurrent topics in Hayes M. Dansky's work include Lipoproteins and Cardiovascular Health (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and Atherosclerosis and Cardiovascular Diseases (11 papers). Hayes M. Dansky is often cited by papers focused on Lipoproteins and Cardiovascular Health (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and Atherosclerosis and Cardiovascular Diseases (11 papers). Hayes M. Dansky collaborates with scholars based in United States, Australia and United Kingdom. Hayes M. Dansky's co-authors include Jonathan D. Smith, Jan L. Breslow, Edward A. Fisher, Yale Mitchel, Sukrut Shah, Eliot A. Brinton, Philip J. Barter, Antonio M. Gotto, Christopher P. Cannon and Michael H. Davidson and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Hayes M. Dansky

50 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

2010 544 citations Christopher P. Cannon, Sukrut Shah et al. New England Journal of Medicine profile →
Intensification of Statin Therapy Results in a Rapid Reduction in Atherosclerotic Inflammation

2013 304 citations Ahmed Tawakol, Zahi A. Fayad et al. Journal of the American College of Cardiology profile →

Peers

Hayes M. Dansky

SURGE

IMMUN

EDM

CCM

Thomas O. McDonald United States

Rui‐Xia Xu China

Jeffrey Kroon Netherlands

Judy G. Verstuyft United States

Kerry-Anne Rye Australia

Patrick M. Moriarty United States

Takahiko Naruko Japan

Kuang‐Yuh Chyu United States

Shusuke Yagi Japan

John W. Gaubatz United States

Thomas O. McDonald United States

Hayes M. Dansky

1.1k ×0.6

SURGE

1.2k ×1.2

IMMUN

464 ×0.5

EDM

1.4k ×1.7

689 ×0.8

CCM

Citations per year, relative to Hayes M. Dansky Hayes M. Dansky (= 1×) peers Thomas O. McDonald

Countries citing papers authored by Hayes M. Dansky

Since Specialization

Citations

This map shows the geographic impact of Hayes M. Dansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hayes M. Dansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hayes M. Dansky more than expected).

Fields of papers citing papers by Hayes M. Dansky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hayes M. Dansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hayes M. Dansky. The network helps show where Hayes M. Dansky may publish in the future.

Co-authorship network of co-authors of Hayes M. Dansky

This figure shows the co-authorship network connecting the top 25 collaborators of Hayes M. Dansky. A scholar is included among the top collaborators of Hayes M. Dansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hayes M. Dansky. Hayes M. Dansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Petit, Chantal, Hayes M. Dansky, Min Lin, et al.. (2025). Design of RESOLVE Lung, a multinational Phase 2, randomized, placebo-controlled trial of the anti-GM-CSF monoclonal antibody namilumab in patients with chronic pulmonary sarcoidosis. Contemporary Clinical Trials. 158. 108078–108078.

Randall, Jason A., Robert J. Sanchez, Hayes M. Dansky, et al.. (2019). Symptoms and Dietary Impact in Hypertriglyceridemia-Associated Pancreatitis: Development and Content Validity of Two New Measures. PharmacoEconomics - Open. 4(1). 191–201. 4 indexed citations

Ahmad, Zahid, Poulabi Banerjee, Sara Hamon, et al.. (2019). Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia. Circulation. 140(6). 470–486. 178 indexed citations

McLaren, David G., Stephen F. Previs, Robert D. Phair, et al.. (2016). Evaluation of CETP activity in vivo under non-steady-state conditions: influence of anacetrapib on HDL-TG flux. Journal of Lipid Research. 57(3). 398–409. 9 indexed citations

Tawakol, Ahmed, Zahi A. Fayad, Robin Mogg, et al.. (2013). Intensification of Statin Therapy Results in a Rapid Reduction in Atherosclerotic Inflammation. Journal of the American College of Cardiology. 62(10). 909–917. 304 indexed citations breakdown →

Myers, Kelly S., James H.F. Rudd, Eric Hailman, et al.. (2012). Correlation Between Arterial FDG Uptake and Biomarkers in Peripheral Artery Disease. JACC. Cardiovascular imaging. 5(1). 38–45. 43 indexed citations

Gotto, Antonio M., Christopher P. Cannon, Sukrut Shah, et al.. (2011). Abstract 15035: Effects on Lipids and Safety Following Cessation of Treatment with Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients with or at High Risk for Coronary Heart Disease. Circulation. 124(10). 3673–81. 4 indexed citations

Dansky, Hayes M., Daniel M. Bloomfield, Patrice H. Gibbons, et al.. (2011). Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia. American Heart Journal. 162(4). 708–716. 24 indexed citations

Gutstein, David E., Rajesh Krishna, Douglas G. Johns, et al.. (2011). Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction. Clinical Pharmacology & Therapeutics. 91(1). 109–122. 47 indexed citations

10.

Krauss, Ronald M., Cathy Anne Pinto, Yang Liu, et al.. (2011). Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib. Journal of Lipid Research. 53(3). 540–547. 69 indexed citations

11.

Cannon, Christopher P., Sukrut Shah, Hayes M. Dansky, et al.. (2010). Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease. New England Journal of Medicine. 363(25). 2406–2415. 544 indexed citations breakdown →

12.

Shan, Jian, et al.. (2008). Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors. Proceedings of the National Academy of Sciences. 105(48). 19006–19011. 46 indexed citations

13.

Shaywitz, David A. & Hayes M. Dansky. (2007). Found in translation. Nature Biotechnology. 25(5). 601–601. 1 indexed citations

14.

Smith, Jonathan D., Hayes M. Dansky, Megan Settle, et al.. (2006). Transcriptome profile of macrophages from atherosclerosis-sensitive and atherosclerosis-resistant mice. Mammalian Genome. 17(3). 220–229. 16 indexed citations

15.

Wang, Wenjun, et al.. (2006). Homozygous disruption of Pctp modulates atherosclerosis in apolipoprotein E-deficient mice. Journal of Lipid Research. 47(11). 2400–2407. 6 indexed citations

16.

Smith, Jonathan D., Hayes M. Dansky, & Jan L. Breslow. (2001). Genetic Modifiers of Atherosclerosis in Mice. Annals of the New York Academy of Sciences. 947(1). 247–253. 17 indexed citations

17.

Rong, James X., et al.. (2000). A transplant model to study the long term effects of apoprotein AI overexpression on large, complex atherosclerotic lesions in ApoE-deficient mice. Circulation. 102. 253–253. 2 indexed citations

18.

Dansky, Hayes M., Courtenay B. Barlow, Minna Tamminen, et al.. (1999). Apo A-I inhibits foam cell formation in apo E–deficient mice after monocyte adherence to endothelium. Journal of Clinical Investigation. 104(1). 31–39. 65 indexed citations

19.

Villiers, Willem J.S. de, et al.. (1998). Macrophage Phenotype in Mice Deficient in Both Macrophage-Colony–Stimulating Factor (Op) and Apolipoprotein E. Arteriosclerosis Thrombosis and Vascular Biology. 18(4). 631–640. 69 indexed citations

20.

Charney, Alan N. & Hayes M. Dansky. (1990). Additive effects of ileal secretagogues in the rat. Gastroenterology. 98(4). 881–887. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact